Prime Medicine, Inc. Common Stock (PRME) financials · rev $4.6M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Prime Medicine, Inc. Common Stock (PRME) rev $4.6M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $4.63M | $2.98M |
| Operating Income | -$208.3M | -$202.5M |
| Net Income | -$201.1M | -$195.9M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $342.7M | $297.5M |
| Current Assets | $181.3M | $211.9M |
| Cash & Equivalents | $63.0M | $182.5M |
| PP&E | $20.6M | $24.4M |
| Total Liabilities | $221.9M | $144.4M |
| Current Liabilities | $37.4M | $38.0M |
| Shareholders' Equity | $120.9M | $153.1M |
| Retained Earnings | -$888.4M | -$687.2M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$162.6M | -$122.9M |
| CapEx | $4.53M | $7.29M |
| Investing Cash Flow | -$108.8M | $68.5M |
| Financing Cash Flow | $151.5M | $195.9M |
| Net Change in Cash | -$119.8M | $141.5M |
| Free Cash Flow | -$167.1M | -$130.2M |
FAQ
What is PRME P/E and revenue?
Prime Medicine, Inc. Common Stock (PRME) rev $4.6M.
What is PRME revenue?
Prime Medicine, Inc. Common Stock last cached revenue is $4.63M (FY2025).
Is PRME profitable?
Prime Medicine, Inc. Common Stock last cached net income is -$201.1M (FY2025).
What are PRME total assets?
Prime Medicine, Inc. Common Stock last cached total assets are $342.7M (FY2025).
What is PRME free cash flow?
Prime Medicine, Inc. Common Stock last cached free cash flow is -$167.1M (FY2025).
Not investment advice. Cached statements, not a live tape.